Release Date: 2024-05-28

Alzheimer’s Disease and Dementia: Epidemiology, Social and Economic Challenge

Ani Hande Mete (Author), Canser Boz (Author)

Release Date: 2024-05-28

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that primarily affects the elderly, leading to severe cognitive decline and memory loss. The global prevalence of Alzheimer’s is rising rapidly due to increasing life expectancy and an aging population. As of 2023, it is estimated that over 50 million people worldwide are living with Alzheimer’s disease. [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inAlzheimer’s Disease From Molecular Mechanisms to Clinical Practices
First Page77
Last Page92
DOIhttps://doi.org/10.69860/nobel.9786053359166.3
ISBN978-605-335-916-6 (PDF)
LanguageENG
Page Count16
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that primarily affects the elderly, leading to severe cognitive decline and memory loss. The global prevalence of Alzheimer’s is rising rapidly due to increasing life expectancy and an aging population. As of 2023, it is estimated that over 50 million people worldwide are living with Alzheimer’s disease. The socioeconomic burden of Alzheimer’s disease is immense, encompassing direct medical costs, indirect costs, and the emotional toll on patients and their families. Direct medical costs include expenses for diagnosis, treatment, and long-term care. These costs are substantial because Alzheimer’s patients often require continuous care, including home care services, assisted living, and nursing home care. The indirect costs primarily involve lost productivity, both from patients who can no longer work and from caregivers who may reduce their working hours or leave their jobs to provide care. The emotional and psychological burden on caregivers is also significant. Family members and friends who provide care often experience high levels of stress, depression, and physical health issues. The time-intensive nature of caregiving can strain personal relationships and reduce the quality of life for both caregivers and patients. Efforts to address the socioeconomic impact of Alzheimer’s disease involve a multifaceted approach, including advancing research for early diagnosis and treatment, improving care facilities, and providing support systems for caregivers. Public health strategies also emphasize the importance of lifestyle changes and preventive measures that may reduce the risk of developing Alzheimer’s. The section provides a comprehensive overview of Alzheimer’s Disease, beginning with its epidemiology, and examining the social and economic challenges.. The section examines demographic shifts, such as aging populations, that increase Alzheimer’s prevalence and considers the implications for public policy and resource allocation for care. This part of the book also examines the social and economic challenges posed by Alzheimer’s Disease, and the direct and indirect costs associated with the disease, including medical care, lost productivity, and the emotional and financial impact on caregivers.

Ani Hande Mete (Author)
Istanbul Cerrahpasa University
https://orcid.org/0000-0002-4077-2895
3Anı Hande Mete graduated from the Department of Health Management at the Faculty of Health Sciences, Ankara University in 2017, and from the Health Management Master’s Program at Hacettepe University, Institute of Social Sciences in 2021. She is currently a PhD candidate in the Health Management Doctoral Program at the Istanbul University-Cerrahpaşa Graduate Education Institute, working on her dissertation. Additionally, since 2019, she has been serving as a Research Assistant in the Department of Health Management, Division of Health Economics at the Faculty of Health Sciences, Istanbul University-Cerrahpaşa. Her research interests include health management, health economics, health expenditures, machine learning.

Canser Boz (Author)
Associate Professor, Istanbul Cerrahpasa University
https://orcid.org/0000-0002-6136-4479
3Associate Professor Canser Boz graduated from the Department of Economics at Anadolu University’s Faculty of Economics and Administrative Sciences in 2012, from the Health Management Master’s Program at Istanbul University’s Institute of Health Sciences in 2016, and from the Health Management PhD Program at Istanbul University-Cerrahpasa in 2020. Boz worked as a Research Assistant in the Department of Health Management, Division of Health Economics at Istanbul University-Cerrahpasa Faculty of Health Sciences, starting in 2013, for eight years. Additionally, in 2019, Boz worked as a researcher in the Department of Economics and Management at the University of Pisa, Italy. Since 2021, Boz has been serving as a faculty member at Istanbul University-Cerrahpaşa Faculty of Health Sciences. Boz has held administrative roles at the university, including Faculty Board Membership, Vice Department Head, and various coordinator and representative positions. His areas of study include health economics, health expenditures, and quantitative data analysis.

  • Gürvit İH. Dementia Syndrome, Alzheimer's Disease, and Non-Alzheimer Dementias. In: Öge AE, Baykan B, editors. Alzheimer's Disease and Non-Alzheimer Dementias. 1st ed. Istanbul: Nobel Medical Publishing House.

  • Tanrıdağ O. Theory and Practice of Behavioral Neurology. Istanbul: Nobel Medical Bookstores; 1994.

  • Karaman Y. Alzheimer's Disease and Other Dementias. Kayseri: Lebib Yalkın Printing House; 2002.

  • Can E. The Language Use of Turkish Alzheimer Patients: An Examination in Terms of Sentence Types. Izmir: Dokuz Eylül University, Institute of Social Sciences; 2016.

  • Taneli B. Alzheimer's Disease and Prevention Strategies in Geriatric Psychiatry. 2019. Available from: https://www.bto.org.tr/wp-content/uploads/2019/10/Geriatrik-Psikiatride-Alzheimer-Hastaligi-bilgen-taneli.pdf (Accessed 18 April 2024).

  • Mayeux R, Stern Y. Epidemiology of alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(8).

  • Global Health Data. 2024. Global Burden of Disease. Available from: https://vizhub.healthdata.org/gbd-results/?params=gbd-api-2019-public/26320faa1d98ae370732e2e3df75ec50 (Accessed 21 April 2024).

  • IHME. 2019. Global Burden of Disease. Available from: https://vizhub.healthdata.org/gbd-results/?params=gbd-api-2019-public/26320faa1d98ae370732e2e3df75ec50 (Accessed 21 April 2024).

  • Wong W. Economic burden of Alzheimer disease and managed care considerations. Am J Manag Care. 2020;26(8): 177-183.

  • Wang Q, Brenner S, Kalmus O, Banda HT, Allegri MD. The economic burden of chronic noncommunicable diseases in rural Malawi: an observational study. BMC Health Serv Res. 2016; 16:1-9.

  • Bessey LJ, Walaszek A. Management of Behavioral and Psychological Symptoms of Dementia. Curr Psychiatry Rep. 2019; 21:66.

  • Pinyopornpanish K, Soontornpun A, Wongpakaran T, Wongpakaran N, Tanprawate S, Pinyopornpanish K, et al. Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes. Sci Rep. 2022; 12:14138.

  • Kim B, Noh GO, Kim K. Behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease and family caregiver burden: a path analysis. BMC Geriatr. 2021; 21:160.

  • Nguyen T, Li X. Understanding public-stigma and self-stigma in the context of dementia: A systematic review of the global literature. Dementia. 2020;19(2):148-181.

  • Rewerska-Juśko M, Rejdak K. Social Stigma of People with Dementia. J Alzheimer's Dis. 2020;78(4):1339–1343.

  • Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D, Bloom DE. Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach. EClinicalMedicine. 2022;51.

  • Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing Alzheimer’s disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res. 2017;17(2):189-202.

  • Castro DM, Dillon C, Machnicki G, Allegri RF. The economic cost of Alzheimer's disease: Family or public health burden? Dement Neuropsychol. 2010;4(4):262-267.

  • Alzheimer's Disease International. 2018. World Alzheimer Report. Available from: https://www.alzint.org/resource/world-alzheimer-report-2018/ (Accessed 20 April 2024).

  • Alzheimer’s Research UK. 2024. The Economic Impact of Dementia. Available from: https://dementiastatistics.org/statistics/the-economic-impact-of-dementia/ (Accessed 20 April 2024).

  • Eroymak S, Yiğit V. Cost of Alzheimer's Disease. Suleyman Demirel University Journal of Social Sciences Institute. 2017;(29):167-196.

  • Jönsson L. The personal economic burden of dementia in Europe. Lancet Reg Health Eur. 2022; 20:100472.

  • Zencir M, Kuzu N, Beşer NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry. 2005;20(7):616-22.

  • Tampi RR, Bhattacharya G, Marpuri P. Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the Era of Boxed Warnings. Curr Psychiatry Rep. 2022; 24:431–440.

  • Lourida I, Gwernan-Jones R, Abbott R, Rogers M, Green C, Ball S, et al. Activity interventions to improve the experience of care in hospital for people living with dementia: a systematic review. BMC Geriatr. 2020;20(1):131.

  • Meyer C, O'Keefe F. Non-pharmacological interventions for individuals with dementia: A review of reviews. Dementia (London). 2018;19(6):1927–1954.

  • Kyung HL, Ji YL, Bora K. Person-centered care in persons living with dementia: A Systematic Review and Meta-analysis. The Gerontologist. 2022;62(4):253-264.

  • Barreto Pde S, Demougeot L, Pillard F, Lapeyre-Mestre M, Rolland Y. Managing behavioral and psychological symptoms in persons with dementia through exercise training: a systematic review and meta-analysis. Ageing Res Rev. 2015; 24:274–285.

  • Kim S, Anstey KJ, Mortby ME. Who displays dementia-related stigma and what does the general public know about dementia? Findings from a nationally representative survey. Aging & Mental Health. 2023;27(6):1111–1119.

  • Behrman S, Chouliaras L, Ebmeier KP. Considering the senses in the diagnosis and management of dementia. Maturitas. 2014;77(4):305-310.

  • Legere LE, McNeill S, Schindel Martin L, Acorn M, An D. Nonpharmacological approaches for behavioural and psychological symptoms of dementia in older adults: A systematic review of reviews. J Clin Nurs. 2018;27(7-8).

  • Sienna C, Erin DD, Aimee D, David RS. Nonpharmacological Management of Behavioral and Psychological Symptoms of Dementia: What Works, in What Circumstances, and Why? Innovation in Aging. 2017;1(3).

  • Kales HC, Gitlin LN, Stanislawski B, Myra Kim H, Marx K, Turnwald M, et al. Effect of the We Care Advisor on family caregiver outcomes in dementia: a pilot randomized controlled trial. BMC Geriatr. 2018; 18:1-12.

  • Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE et al. Alzheimer's disease. Lancet. 2021; 397:1577-1590.

  • Conti Filho CE, Loss LB, Marcolongo-Pereira C, Rossoni Junior JV, Barcelos RM, Chiarelli-Neto O, et al. Advances in Alzheimer's disease's pharmacological treatment. Front Pharmacol. 2023; 14:1101452.

  • Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. Overview of pharmacological and non-pharmacological interventions for the treatment of behavioural and psychological symptoms of dementia. Int Psychogeriatr. 2018;30(3):295–309.

  • Jennings AA, Foley T, Walsh KA, Coffey A, Browne JP, Bradley CP. General practitioners' knowledge, attitudes, and experiences of managing behavioural and psychological symptoms of dementia: A mixed-methods systematic review. Int J Geriatr Psychiatry. 2018;33(9):1163–1176.

  • Magierski R, Sobow T, Schwertner E, Religa D. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress. Front Pharmacol. 2020;31(11):1168.

  • Maneemai O, Cujilan Alvarado MC, Calderon Intriago LG, Donoso Triviño AJ, Franco Coffré JA, Pratico D, et al. Sensory Integration: A Novel Approach for Healthy Ageing and Dementia Management. Brain Sci. 2024;14(3):285.

  • Prémont L. Towards Navigational Aids using Augmented Reality for People with Alzheimer’s Disease in Outdoor Environments: A user study using HoloLens 2 around a University campus. 2023.

  • Assistant Secretary for Planning and Evaluation (ASPE), 2024, U.S. Department of Health and Human Services, National Plan to Address Alzheimer's Disease. Available from: https://aspe.hhs.gov/national-plan-address-alzheimers-disease#main-content (Accessed 19 April 2024).

  • Bachmann P, Hruska J. Alzheimer caregiving problems according to ADLs: evidence from Facebook support groups. Int J Environ Res Public Health. 2002;19(11):6423.

  • Wilkerson DA, Brady E, Yi EH, Bateman DR. Friendsourcing Peer Support for Alzheimer’s Caregivers Using Facebook Social Media. J Technol Hum Serv. 2018; 36:105–124.

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!